London Health Sciences Center
London, Ontario, N6A 4G5, Canada
NCT Number: NCT00724633
Patients currently receiving hemodialysis will be randomized to receive 1 of 3 dialysate sodium prescriptions. The effects on blood pressure, interdialytic weight gain, thirst, and intradialytic symptoms will be assessed.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
London, Ontario, N6A 4G5, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Please see above
Time frame: 3 months
Ambulatory blood pressure to be taken over 24 hours at 4 week intervals throughout the study
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients: a Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07334522
Agnosia, Anxiety
Karbala, Iraq
View Trial DetailsNCT06759376
Chronic Disease, Chronic Kidney Disease
Eskişehir, Turkiye, Turkey (Türkiye)
View Trial DetailsNCT07687498
Chronic Disease, Disease Attributes
Mersin, Yenişehir, Turkey (Türkiye)
View Trial Details